>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 20, 2013

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance

Summary:

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

ASA Nominates James P. Rathmell M.D. and Richard W. Rosenquist M.D. to Pain Care Committees

Tuesday, August 24, 2010

ASA recently nominated two of its members to committees that will be examining issues related to pain care. Dr. James P. Rathmell was nominated to the Institute of Medicine (IOM) Committee on Advancing Pain Research, Care, and Education. This committee will be charged with reviewing current science related to pain care and making recommendations to advance the field. The IOM is expected to announce committee membership at the end of September.

Dr. Richard W. Rosenquist was nominated to the National Institutes of Health (NIH) Interagency Pain Research Coordinating Committee (IPRCC). The purpose of the IPRCC will be to summarize current pain care research, identify gaps in research, and enhance coordination of clinical research on pain causes and treatments. The Secretary of the Department of Health and Human Services (HHS) is expected to establish the IPRCC no later than March 23, 2011.

Dr. Rosenquist Nomination Letter

Dr. Rathmell Nomination Letter

« Back to Washington Alerts